SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 396 filers reported holding SEATTLE GENETICS INC in Q3 2020. The put-call ratio across all filers is 0.61 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $622,000 | -10.5% | 3,550 | 0.0% | 0.03% | -20.6% |
| Q3 2020 | $695,000 | +15.3% | 3,550 | 0.0% | 0.03% | +3.0% |
| Q2 2020 | $603,000 | +47.1% | 3,550 | 0.0% | 0.03% | +22.2% |
| Q1 2020 | $410,000 | +1.0% | 3,550 | 0.0% | 0.03% | +28.6% |
| Q4 2019 | $406,000 | +34.0% | 3,550 | 0.0% | 0.02% | +23.5% |
| Q3 2019 | $303,000 | +8.2% | 3,550 | -12.3% | 0.02% | +6.2% |
| Q2 2019 | $280,000 | -14.1% | 4,050 | -9.0% | 0.02% | -20.0% |
| Q1 2019 | $326,000 | +29.4% | 4,450 | 0.0% | 0.02% | +11.1% |
| Q4 2018 | $252,000 | -26.5% | 4,450 | 0.0% | 0.02% | -14.3% |
| Q3 2018 | $343,000 | -35.0% | 4,450 | -50.0% | 0.02% | +23.5% |
| Q2 2018 | $528,000 | +126.6% | 8,900 | +100.0% | 0.02% | +6.2% |
| Q1 2018 | $233,000 | -17.1% | 4,450 | -15.2% | 0.02% | -15.8% |
| Q4 2017 | $281,000 | – | 5,250 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lagoda Investment Management, L.P. | 57,170 | $10,013,000 | 5.39% |
| Boxer Capital, LLC | 400,000 | $70,056,000 | 2.25% |
| PARTNERS CAPITAL INVESTMENT GROUP, LLP | 110,153 | $19,292,000 | 1.10% |
| DCF Advisers, LLC | 13,300 | $2,329,000 | 0.96% |
| XTX MARKETS LLC | 2,418 | $423,000 | 0.87% |
| FAIRFIELD, BUSH & CO. | 15,035 | $2,633,000 | 0.77% |
| Parcion Private Wealth LLC | 4,520 | $792,000 | 0.10% |
| Gulf International Bank (UK) Ltd | 26,091 | $4,569,000 | 0.06% |
| Princeton Portfolio Strategies Group LLC | 1,500 | $263,000 | 0.05% |
| Redpoint Investment Management Pty Ltd | 2,392 | $419,000 | 0.04% |